Journal Article DZNE-2026-00549

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Evaluation of fully automated ApoE4 proteotyping for APOE ε4 genotype estimation in the FINDERI cohort.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2026
Wiley Hoboken, NJ

Alzheimer's & dementia / Diagnosis, assessment & disease monitoring 18(2), e70362 () [10.1002/dad2.70362]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: Carriers of the ε4 allele of the apolipoprotein E (APOE) gene have an increased risk for Alzheimer's disease (AD) and amyloid-related imaging abnormalities (ARIAs) upon anti-amyloid beta (Αβ) immunotherapy. Measuring apoE4 and pan-apoE proteins in blood plasma for apoE4 proteotyping may offer an alternative to APOE genotyping.We assessed apoE4 proteotyping accuracy in 479 participants of the prospective FINd DElirium RIsk factors (FINDERI) study in patients undergoing cardiac surgery and compared results to quantitative polymerase chain reaction (qPCR) genotyping.Proteotype-genotype discordance occurred in 8 of 479 participants (1.67%). Five of 17 proteotype homozygotes were genotypically heterozygous. Replacing manufacturer provided cut points with custom data-driven thresholds substantially improved classification performance.We confirm the reported overall high classification performance of apoE4 proteotyping but underscore the need to re-evaluate the generalizability of the cut points provided with the assay kits. Misclassification of heterozygous APOE ε4 carriers as homozygous could erroneously exclude eligible patients from anti-amyloid therapies.

Keyword(s): ARIA risk ; Alzheimer's disease ; apolipoprotein E ; dementia ; genotype ; plasma ; proteotype ; risk factor

Classification:

Contributing Institute(s):
  1. Molecular biomarkers for predictive diagnostics of neurodegenerative diseases (AG Wiltfang)
Research Program(s):
  1. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)

Database coverage:
Medline ; DOAJ ; Article Processing Charges ; Clarivate Analytics Master Journal List ; DEAL Wiley ; DOAJ Seal ; Emerging Sources Citation Index ; Fees ; IF >= 5 ; JCR ; PubMed Central ; SCOPUS ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Institute Collections > GÖ DZNE > GÖ DZNE-AG Wiltfang
Documents in Process
Public records
In process

 Record created 2026-05-22, last modified 2026-05-22


Restricted:
Download fulltext PDF Download fulltext PDF (PDFA)
External link:
Download fulltextFulltext by Pubmed Central
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)